Chief of Vascular and Endovascular Surgery at Massachusetts General Hospital Joins Nectero Medical Advisory Team

Nectero Medical Inc. (Nectero) announced today that Matthew J. Eagleton, MD, Chief of Vascular and Endovascular Surgery at the Massachusetts General Hospital, has joined the Nectero Medical Advisory Team.

“We are elated to have Dr. Eagleton join the Nectero Medical Advisory Team,” stated Eric Wells, CEO of Telluride Medical Partners, the company that manages Nectero. “Dr. Eagleton is an accomplished vascular surgeon and an international expert on the treatment of complex aortic disease with endovascular therapy, and will be a key member of the Nectero Medical Advisory Team,” stated Wells.
 
Dr. Eagleton is the Chief of Vascular and Endovascular Surgery at the Massachusetts General Hospital and Co-director of the Fireman Vascular Center. Dr. Eagleton received his medical degree (1994) and completed his residency (General Surgery, 2000) from the University of Rochester. He completed specialty training in Vascular Surgery at the University of Michigan in 2002 and obtained advanced training in endovascular procedures at the Cleveland Clinic.

Prior to his current role at Massachusetts General Hospital, Dr. Eagleton was Professor of Surgery at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, and Vice-Chairman of the Department of Vascular Surgery and Vascular Surgery Director of the Cleveland Clinic Aortic Center.

About Nectero Medical Inc.
Founded in 2017, Nectero is focused on the development of an innovative treatment for Abdominal Aortic Aneurysms (AAA). Nectero’s mission is to address the problem of vascular aneurysms by shifting the treatment paradigm from invasive repair to minimally invasive prevention, starting in the aorta. Nectero’s technology will improve the lives of the millions of patients who are diagnosed with AAA disease and reduce systemic healthcare costs.